13G Filing: Visium Asset Management Has Nearly Doubled Its Stake in La Jolla Pharmaceutical Co (LJPC)

Page 10 of 12

Page 10 of 12 SEC Filing


CUSIP No. 503459604 Page
10
of 12Pages
(c) Number of Shares as to which person has:
(i) sole power to vote or to direct vote:

None

(ii) shared power to vote or to direct vote:

1,182,013 shares

(iii) sole power to dispose or direct disposition of:

None

(iv) shared power to dispose or to direct disposition of:

1,182,013 shares

VAM, JG Asset and Gottlieb disclaim beneficial ownership as to the Securities, except to the extent of his or its pecuniary interests therein. Neither
the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of the other individual officers and members of VBMF, VAM or JG Asset is, for any purpose, the beneficial owner of any of the Securities.

Item 5 Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
The securities reported in this Schedule 13G, which are beneficially owned by VAM, JG Asset and Gottlieb, are owned by VBMF, an advisory client of VAM.
Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
Not Applicable
Item 9 Notice of Dissolution of Group:
Not Applicable

Page 10 of 12 Pages

Follow La Jolla Pharmaceutical Co (NASDAQ:LJPC)

Page 10 of 12